Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Izotropic Corp (CSE: IZO )

0.2350 -0.0200 (-7.84%)
Official Closing Price Updated: 3:49 PM EST, Jan 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Izotropic Corp

Izotropic Files Pre-Submission with U.S. FDA for Breast Cancer Screening
-A screening indication for women with dense breast tissue adjunctive to 3D mammography increases the market size for annual IzoView... 
Via Newsfile
Exposures Product Safety
Izotropic Provides Regulatory and Operational Updates
VANCOUVER, BC – TheNewswire - January 8, 2024 – Izotropic Corporation (“Izotropic” or the “Company”) (CSE:IZO) (OTC:IZOZF) (FSE:1R3), a medical device company commercializing IzoView, a CT (computed... 
Via TheNewswire.com
Exposures Product Safety
Izotropic Announces AGM Results
VANCOUVER, BC – TheNewswire - December 22, 2023 – Izotropic Corporation (“Izotropic” or the“Company”) (CSE:IZO) (OTC:IZOZF) (FSE:1R3), a medical device company commercializing IzoView, a CT (computed... 
Via TheNewswire.com
Izotropic Completes Pre-Submission Meeting With U.S. FDA
VANCOUVER, BC, November 1, 2023 – TheNewswire – Izotropic Corporation (“Izotropic” or the “Company”) (CSE:IZO) (OTC:IZOZF) (FSE:1R3), a medical device company commercializing IzoView, a CT (computed... 
Via TheNewswire.com
Exposures Product Safety
Izotropic Confirms FDA Pre-Submission Meeting Date
Vancouver, BC - TheNewswire - September 27, 2023 - Izotropic Corporation (“Izotropic” or the “Company”) (CSE:IZO) (OTC:IZOZF) (FSE:1R3), a medical device company commercializing IzoView, a CT (computed... 
Via TheNewswire.com
Exposures Product Safety
Izotropic Closes Non-Brokered Private Placement
Vancouver, BC - TheNewswire - September 20, 2023 - Izotropic Corporation (“Izotropic” or the “Company”) (CSE: IZO) (OTCQ: IZOZF) (FSE: 1R3), a medical device company commercializing IzoView, a CT... 
Via TheNewswire.com
Izotropic Corporation Announces Non-Brokered Private Placement
Vancouver, BC - TheNewswire - September 13, 2023 - Izotropic Corporation (“Izotropic” or the “Company”) (CSE:IZO) (OTC:IZOZF) (FSE:1R3), a medical device company commercializing IzoView, a CT (computed... 
Via TheNewswire.com
Izotropic Files Class II Pre-Submission with FDA & Releases Details on Predicate Devices
Via TheNewswire.com
Exposures Product Safety
Izotropic Engages Market Awareness Consultant
VANCOUVER, BC – TheNewswire - JUNE 27, 2023 – Izotropic Corporation (“Izotropic” or the “Company”) (CSE:IZO) (OTC:IZOZF) (FSE:1R3), a medical device company commercializing IzoView, a 360-degree... 
Via TheNewswire.com
Izotropic Modifies Market Approval Pathway & Strategy
VANCOUVER, BC – TheNewswire - JUNE 20, 2023 – Izotropic Corporation (“Izotropic” or the “Company”) (CSE:IZO) (OTC:IZOZF) (FSE:1R3), a medical device company commercializing IzoView, a 360-degree... 
Via TheNewswire.com
Exposures Product Safety
Izotropic Completes QSUB Meeting With FDA Regarding Clinical Study Acceleration
VANCOUVER, BC – TheNewswire - May 15, 2023 – Izotropic Corporation (“Izotropic” or the “Company”) (CSE:IZO) (OTC:IZOZF) (FSE:1R3), a medical device company commercializing IzoView, a dedicated breast... 
Via TheNewswire.com
Exposures Product Safety
Izotropic Provides Business Update
VANCOUVER, BC – TheNewswire - April 27, 2023 – Izotropic Corporation (“Izotropic” or the “Company”) (CSE:IZO) (OTC:IZOZF) (FSE:1R3), a medical device company commercializing IzoView, a dedicated breast... 
Via TheNewswire.com
Izotropic to Extend Period for Unsecured Loans
Vancouver, BC - TheNewswire - March 29, 2023 - Izotropic Corporation (“Izotropic” or the “Company”) (CSE:IZO) (OTC:IZOZF) (FSE:1R3), a medical device company commercializing IzoView, a dedicated breast... 
Via TheNewswire.com
Izotropic's Izoview Breast CT Device to be Featured on Advancements TV Show in USA
VANCOUVER, BC – TheNewswire - January 13, 2023 – Izotropic Corporation (“Izotropic” or the “Company”) (CSE:IZO) (OTC:IZOZF) (FSE:1R3), a medical device company commercializing IzoView, a dedicated... 
Via TheNewswire.com
Izotropic Creates Compensation Committee and Adopts Charter
Vancouver, BC - TheNewswire - January 12, 2023 - Izotropic Corporation (“Izotropic” or the “Company”) (CSE:IZO) (OTC:IZOZF) (FSE:1R3), a medical device company commercializing IzoView, a dedicated... 
Via TheNewswire.com
Izotropic Releases First Video of IzoView
Vancouver, British Columbia--(Newsfile Corp. - January 9, 2023) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the... 
Via Newsfile
Izotropic Releases First Video of Izoview
VANCOUVER, BC – TheNewswire - January 9, 2023 – Izotropic Corporation (“Izotropic” or the “Company”) (CSE:IZO) (OTC:IZOZF) (FSE:1R3), a medical device company commercializing IzoView, a dedicated... 
Via TheNewswire.com
Izotropic Reports Board Meeting Results
VANCOUVER, BC – TheNewswire - January 4, 2023 – Izotropic Corporation (“Izotropic” or the “Company”) (CSE:IZO) (OTC:IZOZF) (FSE:1R3), a medical device company commercializing IzoView, a dedicated... 
Via TheNewswire.com
Izotropic Delays Announcements to 2023, Holds Board Meeting
VANCOUVER, BC – TheNewswire - December 28, 2022 – Izotropic Corporation (“Izotropic” or the “Company”) (CSE:IZO) (OTC:IZOZF) (FSE:1R3), a medical device company commercializing IzoView, a dedicated... 
Via TheNewswire.com
Izotropic Announces 2022 AGM Results and Clarifies Restating of Financial Statements
VANCOUVER, BC – TheNewswire - December 20, 2022 – Izotropic Corporation (“Izotropic” or the “Company”) (CSE:IZO) (OTC:IZOZF) (FSE:1R3), a medical device company commercializing IzoView, a dedicated... 
Via TheNewswire.com
Izotropic Completes Izoview Development and Assembly, Prepares for Final Testing
VANCOUVER, BC – TheNewswire – December 1 , 2022 – Izotropic Corporation (“Izotropic” or the “Company”) (CSE:IZO) (OTC:IZOZF) (FSE:1R3), a medical device company commercializing IzoView, a dedicated... 
Via TheNewswire.com
Alexander Tokman Joins Izotropic Board Of Directors
VANCOUVER, BC – TheNewswire - November 11, 2022 – Izotropic Corporation (“Izotropic” or the “Company”) (CSE:IZO) (OTC:IZOZF) (FSE:1R3), a medical device company commercializing IzoView, a dedicated... 
Via TheNewswire.com
Topics Artificial Intelligence
Exposures Artificial Intelligence
IZOTROPIC CORPORATION Announces Closing of Non-Brokered Private Placement
THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES 
Via TheNewswire.com
Izotropic Grants Stock Options
VANCOUVER, BC – TheNewswire - November 1, 2022 – Izotropic Corporation (“Izotropic” or the “Company”) (CSE:IZO) (OTC:IZOZF) (FSE:1R3), a medical device company commercializing IzoView, a dedicated... 
Via TheNewswire.com
Izotropic Appoints Medical Device R&D Expert as Executive VP of Product Engineering
Vancouver, British Columbia--(Newsfile Corp. - June 30, 2021) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the... 
Via Newsfile
Topics Intellectual Property
Exposures Intellectual Property
Izotropic Updates Timelines for Clinical Study and Fabrication of Initial Izoview Units
Vancouver, British Columbia--(Newsfile Corp. - June 3, 2021) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or... 
Via Newsfile
Topics Supply Chain
Exposures COVID-19 Product Safety Supply Chain
Izotropic Provides Corporate Update
Vancouver, British Columbia--(Newsfile Corp. - May 27, 2021) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the... 
Via Newsfile
Exposures COVID-19
Tomosynthesis Pioneer Joins Izotropic Scientific Advisory Board
Vancouver, British Columbia--(Newsfile Corp. - April 20, 2021) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or... 
Via Newsfile
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.